ProQR Therapeutics
PRQR
PRQR
27 hedge funds and large institutions have $37.1M invested in ProQR Therapeutics in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
27
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.23M | |
| 2 | +$1.29M | |
| 3 | +$1.12M | |
| 4 |
OPPM
Opus Point Partners Management
New York
|
+$992K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$744K |
Top Sellers
| 1 | -$3.2M | |
| 2 | -$690K | |
| 3 | -$144K | |
| 4 |
PCM
Prelude Capital Management
New York
|
-$71K |
| 5 |
VF
Virtu Financial
New York
|
-$64K |